Hydroxychloroquine Study Retraction

 In Uncategorized

Today in a statement from The Lancet, three of the authors of a study that claimed the malaria drug Hydroxychloroquine, is unsafe have retracted their statements.  Hydroxychloroquine has repeatedly been in the news because the President of the United States announced he is regularly taking the drug in an attempt to protect against Covid-19.

Here is the full statement from The Lancet

“Today, three of the authors of the paper, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”, have retracted their study. They were unable to complete an independent audit of the data underpinning their analysis. As a result, they have concluded that they “can no longer vouch for the veracity of the primary data sources.” The Lancet takes issues of scientific integrity extremely seriously, and there are many outstanding questions about Surgisphere and the data that were allegedly included in this study. Following guidelines from the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE), institutional reviews of Surgisphere’s research collaborations are urgently needed.

The retraction notice is published today, June 4, 2020. The article will be updated to reflect this retraction shortly.”

For more information and news updates regarding Covd-19 and potential treatments and vaccines, check back with the ABN blog frequently.

Recent Posts

Leave a Comment


Start typing and press Enter to search